NeuroOne Medical Tech (NASDAQ: NMTC)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-12 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.200 | -0.190 | 0.0100 | ||||
REV | 36.584K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of NeuroOne Medical Tech (NASDAQ: NMTC) through any online brokerage.
Other companies in NeuroOne Medical Tech’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Ekso Bionics Holdings (NASDAQ:EKSO), Bluejay Diagnostics (NASDAQ:BJDX), Aethlon Medical (NASDAQ:AEMD) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for NeuroOne Medical Tech (NASDAQ: NMTC) was reported by Craig-Hallum on Monday, March 28, 2022. The analyst firm set a price target for 0.00 expecting NMTC to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The stock price for NeuroOne Medical Tech (NASDAQ: NMTC) is $0.8209 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for NeuroOne Medical Tech.
NeuroOne Medical Tech’s Q3 earnings are confirmed for Friday, August 12, 2022.
There is no upcoming split for NeuroOne Medical Tech.
NeuroOne Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.